In March 2022, the Australia government announced $350 million of funding over 4 years to employ on-site pharmacists in residential aged care, starting July 2023. In April 2023, the government made changes to the proposed on-site pharmacists, where the new program will now be delivered by and through community pharmacies. Regardless of how the model will be implemented, the goal remains the same – to improve quality use of medicines and medicines safety for aged care residents.
While it is relatively easy for pharmacists to monitor and manage some types of medicine harms (e.g., due to use of inappropriate medicines), many medicines can cause “milder” harms (e.g., poor balance, sedation) that are difficult to detect without the right tools. Left unmanaged, these “milder” harms can lead to serious adverse events such as injurious falls, according to Pharmacist Julian Soriano talking to Australian Health Journal.
In a joint project between UniSA, Tanunda Luteran Home, Flinders University and UNSW, a digital solution has been used to create an evidence-based, medicines use model to assist pharmacists (on-site aged care or community pharmacists) with actively monitoring medicine harms.
An interdisciplinary team at the University of South Australia (UniSA), University of New South Wales (UNSW) and Flinders University is currently implementing the TeleClinical Care (TCC) platform incorporating data from a suite of digital technologies to enable pharmacist at the Tanunda Lutheran Home (where Julian Soriano works) to actively monitor their aged care residents.
The ARIIA funded project is being conducted in two phases:
i) Phase 1 involves developing protocol to extract data from digital technologies (e.g. activity trackers, sleep tracking mats) into the TCC platform. The core of the existing TCC platform is a dashboard that includes longitudinal visualisations of changes in residents’ health and well-being over time. Other existing data sources collected in residential aged care will be uploaded to the dashboard, including medicine use (e.g. medicine changes, sedative load), clinical care record (e.g. bowel movement) and adverse events (e.g. falls, hospital admission).
ii) Phase 2 involves a pre-post implementation study over 12-weeks, with 30 residents recruited from the Tanunda Lutheran Home. The selected digital technologies will first be installed for all enrolled residents who provided written consent. Enrolled residents will also be asked to use an activity tracker. Prior to service provision, two weeks’ baseline data will be collected from the digital technologies; the data will serve as reference point for future changes. Pharmacists will monitor all participants using the centralised TCC dashboard.
As Soriano states, “A platform like this is going to make that job much more streamlined. And the use of sensors such as a sleep tracker and activity tracker is also going to help provide the pharmacist with more information to be able to make more informed decisions, more informed recommendations for residents, their families and their treating GPs.”
The current workforce challenges in aged care are not forgotten and Soriano expresses hope, that “this platform won’t increase the burden on residents and the staff there in terms of gathering this information. Hopefully this will be quite streamlined and automatic and there won’t be a real big service change for the already overworked nurses and residents living in aged care would just be able to live and not have to worry constantly about being poked and prodded.”
You Might also like
-
Understanding factors of persistent lower back pain in women
Lizzy Quinn is a Musculoskeletal Physiotherapist with 20 years experience focusing on people with spinal pain. Australian Health Journal spoke with Lizzy on the complexities of persistent lower back pain in women.
Lower back pain in women in their 30s, 40s, and 50s is complex to treat due to the combination of physical and emotional factors, and health professionals need to stay updated on best practices and science to provide the best recovery platform for patients. These women typically have busy lives, pressures, and expectations.
-
State of Private Hospitals sector in Australia
During Mr Roff’s working career at APHA he has represented the private hospitals sector to nine different Federal Health Ministers and eight Prime Ministers. He believes the government should take steps to regulate the health insurance industry to protect consumers and ensure that Australians have access to affordable and comprehensive healthcare services.
-
The role of genomic screening in transforming public health
Dr Jane Tiller is a lawyer, genetic counsellor and public health researcher. She is Ethical, Legal & Social Adviser in Public Health Genomics at Monash University, and a National Health and Medical Research Council Investigator Grant holder. Jane is passionate about the use of genomics to prevent disease, and in delivering equitable access to preventive genetic information at the population level. She is co-lead of DNA Screen, a world-first study piloting the offer of preventive DNA screening to the Australian adult population. DNA Screen has tested over 10,000 young people for genetic high risk of medically actionable conditions such as cancer and heart disease, finding about 2% of participants had genetic high risk. Jane is leading efforts to secure Commonwealth Government funding to expand the DNA Screen program, with the eventual goal of the development of a public health population screening program for disease prevention based on high genetic risk.